Implementation and Outcomes Research Awardees
The intent of the Implementation and Outcomes Research grant is to support innovative investigators from eligible organizations to translate promising research and scientific discoveries into the development of tools, devices, technologies, therapeutics, or interventions, that have the potential to address cancer care across the cancer continuum that will ultimately advance cancer care, lessen the burden of cancer, and improve health outcomes.
Cycle 1
April 2025
A Three-in-One HER Family Targeted RNA Drug for Breast Cancer
Dotquant LLC (Principal Investigator: Hongyan Liu, PhD)Partnering with Washington State Tribal Communities to Develop Culturally-Tailored Nutrition Resources and Reduce Cancer Health Disparities
Fred Hutchinson Cancer Center (Principal Investigator: Heather Greenlee, ND, PhD, MPH; Amanda Fretts PhD, MPH)Converting an Immunotherapy Resistance Mechanism into a Vulnerability Using Slow-Release Local Immunotherapy
Seattle Children's Research Institute (Principal Investigator: Jim Olson MD, PhD)Advanced Platform for Developing Conditionally Stable Sensors and Effectors for Cancer Applications
Seattle Children's Research Institute (Principal Investigator: Jonathan Tang, PhD)Development of a Direct Inhibitor of the Brachyury Transcription Factor for Chordoma and Non-Small Cell Lung Cancer
Talus Bioscience, Inc. (Principal Investigator: Alex Federation, PhD)RNA Therapeutics: Bridging the Gap Between Research and Translation
University of Washington (Principal Investigator: Xiaohu Gao, PhD)Workplace Cancer Prevention and Screening: Scaling Up Connect to Wellness for Employees in Low-Wage Industries Across Washington State
University of Washington (Principal Investigator: Peggy Hannon, PhD, MPH)Advancing Merkel Cell Carcinoma Management: Improved Recurrence Detection and New Approaches for Immunotherapy-Refractory Disease
University of Washington (Principal Investigator: Paul Nghiem, MD, PhD)Phase II Randomized Controlled Clinical Trial evaluating a Scalable, Personalized Home-Based Activity Intervention with ExerciseRx in Survivors with Nonmuscle-Invasive Bladder Cancer: The EMPOWER Trial
University of Washington (Principal Investigator: Sarah Psutka, MD, MSc; Cindy Lin, MD, FACSM, FAAPMR)Developing Novel Small Molecule Therapeutics for MYC-Driven Cancers Using Wayfinder Biosciences' Proprietary RNA-Drugging Platform
Wayfinder Biosciences, Inc. (Principal Investigator: David Sparkman-Yager, PhD)